Cargando…
Differential regulation of the REGγ–proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells
Proteasome activity is frequently enhanced in cancer to accelerate metastasis and tumorigenesis. REGγ, a proteasome activator known to promote p53/p21/p16 degradation, is often overexpressed in cancer cells. Here we show that p53/TGF-β signalling inhibits the REGγ–20S proteasome pathway by repressin...
Autores principales: | Ali, Amjad, Wang, Zhuo, Fu, Junjiang, Ji, Lei, Liu, Jiang, Li, Lei, Wang, Hui, Chen, Jiwu, Caulin, Carlos, Myers, Jeffrey N., Zhang, Pei, Xiao, Jianru, Zhang, Bianhong, Li, Xiaotao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876931/ https://www.ncbi.nlm.nih.gov/pubmed/24157709 http://dx.doi.org/10.1038/ncomms3667 |
Ejemplares similares
-
The REGγ-Proteasome Regulates Spermatogenesis Partially by P53-PLZF Signaling
por: Gao, Xiao, et al.
Publicado: (2019) -
REGγ Contributes to Regulation of Hemoglobin and Hemoglobin δ Subunit
por: Zuo, Qiuhong, et al.
Publicado: (2017) -
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
por: Gao, Xiao, et al.
Publicado: (2020) -
Author Correction: The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
por: Gao, Xiao, et al.
Publicado: (2020) -
REGγ regulates circadian clock by modulating BMAL1 protein stability
por: Kubra, Syeda, et al.
Publicado: (2021)